EGFR and non-small cell lung carcinoma: The comparison between mutation status and clinical manifestations in this study confirmed the finding in previous studies that EGFR mutations are frequently present in small subgroups of NSCLC patients, including females, never-smokers, and patients with adenocarcinoma histology, although these findings were not statistically significant.